Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 7, 2011, Pages 1072-1078

  Au, Brandon K C ^a   Au, Margaret A ^b   Chien, Jason W ^c,d  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Allogeneic hematopoietic cell transplantation; Bronchiolitis obliterans syndrome; Chronic graft versus host disease

Indexed keywords

AZITHROMYCIN; BUSULFAN; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN G; METHOTREXATE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; AIRWAY OBSTRUCTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS SYNDROME; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK PATIENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT MONITORING; PREVALENCE; RISK FACTOR; SPIROMETRY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; BUSULFAN; CHRONIC DISEASE; EARLY DIAGNOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SPIROMETRY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79958742154     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.11.018     Document Type: Article

References (19)

1. Afessa B., Litzow M.R., Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 28:425-434.
2. Dudek A.Z., Mahaseth H., DeFor T.E., Weisdorf D.J. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003, 9:657-666.
3. Clark J.G., Schwartz D.A., Flournoy N., Sullivan K.M., Crawford S.W., Thomas E.D. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987, 107:648-656.
4. Holland H.K., Wingard J.R., Beschorner W.E., Saral R., Santos G.W. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988, 72:621-627.
5. Marras T.K., Chan C.K., Lipton J.H., Messner H.A., Szalai J.P., Laupacis A. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004, 33:509-517.
6. Santo Tomas L.H., Loberiza F.R., Klein J.P., et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005, 128:153-161.
7. Curtis D.J., Smale A., Thien F., Schwarer A.P., Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995, 16:169-173.
8. Yoshihara S., Tateishi U., Ando T., et al. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005, 35:1195-1200.
9. Chan C.K., Hyland R.H., Hutcheon M.A., et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 1987, 66:327-340.
10. Clark J.G., Crawford S.W., Madtes D.K., Sullivan K.M. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989, 111:368-376.
11. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
12. Markopoulo K.D., Cool C.D., Elliot T.L., et al. Obliterative bronchiolitis: varying presentations and clinicopathological correlation. Eur Respir J 2002, 19:20-30.
13. Philit F., Wiesendanger T., Archimbaud E., Mornex J.F., Brune J., Cordier J.F. Post-transplant obstructive lung disease ('bronchiolitis obliterans'): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995, 8:551-558.
14. Yokoi T., Hirabayashi N., Ito M., et al. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Nagoya BMT Group. Virchows Arch 1997, 431:275-282.
15. Yoshihara S., Yanik G., Cooke K.R., Mineishi S. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13:749-759.
16. Williams K.M., Chien J.W., Gladwin M.T., Pavletic S.Z. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009, 302:306-314.
17. Crapo R.O., Morris A.H., Gardner R.M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981, 123:659-664.
18. Hsu K.H., Jenkins D.E., Hsi B.P., et al. Ventilatory functions of normal children and young adults-Mexican-American, white, and black. I. Spirometry. J Pediatr 1979, 95:14-23.
19. Chien J.W., Martin P.J., Gooley T.A., et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003, 168:208-214.